Advertisement

Topics

Prana Biotechnology Company Profile

06:08 EST 11th December 2018 | BioPortfolio

Prana Biotechnology has developed a proprietary library of class-leading chemical compounds. This library is combined with a drug development program to explore novel therapeutics in multiple disease indications. The scientific focus of the company is upon neurological diseases, particularly Alzheimer‘s, Parkinson‘s and Huntington‘s diseases. The company listed on the Australian Stock Exchange (ASX code PBT) in March 2000 and listed on the NASDAQ (code PRAN) in September 2002.

Location

Level 2, 369 Royal Parade
Parkville
Victoria
3052
Australia

Contact

Phone: 61 3 9349 4906
Fax: 61 3 9348 0377
Email: info@pranabio.com


News Articles [140 Associated News Articles listed on BioPortfolio]

Prana receives approval for Phase l trial of PBT434

Prana Biotechnology has received approval from the ethics committee to begin a Phase I clinical trial to investigate the safety,...Read More... The post Prana receives approval for Phase l trial of PB...

Prana doses first subject in Phase l trial of PBT434

Prana Biotechnology has dosed the first cohort of subjects in its Phase I clinical trial of PBT434 for the treatment...Read More... The post Prana doses first subject in Phase l trial of PBT434 appear...

Prana to initiate phase 1 trial of PBT434 to treat Parkinsonian diseases

Prana Biotechnology Ltd has received ethics committee approval and has commenced recruitment for its phase I clinical trial evaluating the safety, tolerability and pharmacokinetics of the company's le...

Professor Ira Shoulson, Georgetown University & Prana Biotechnology

Professor Ira Shoulson, Georgetown University & Prana Biotechnology

First Volunteers Dosed in Phase I Clinical Trial of PBT434, Prana’s Lead Therapy for Parkinsonian Diseases

Highlights: Prana enrols and doses its first cohort of healthy volunteers in its Phase I clinical trial Evidence supports activity of PBT...

First Volunteers Dosed in Phase I Clinical Trial of PBT434, Prana’s Lead Therapy for ...

Highlights: Read more...

PBT434 Data to be Presented at the International Congress of Parkinson’s Disease and Movement ...

Prana’s PBT434 prevents neuronal loss in a new model of neurodegeneration Read more...

Prana Biotechnology: Pre-Clinical Evidence Demonstrates PBT434 as a Potential Treatment for MSA

PBT434 prevents alpha-synuclein aggregation, preserves neurons, reduces glial cell inclusions and slows motor dysfunction in an animal model of Multiple System Atrophy ...

Drugs and Medications [3 Associated Drugs and Medications listed on BioPortfolio]

Korres quercetin 7 oak hydrating antiageing and antiwrinkle [Johnson & Johnson Consumer Products Company, Division of Johnson & Johnson Consumer Companies, Inc.]

Korres Quercetin & Oak Day Cream for Normal to Dry Skin SPF 4

Bio-active anti-aging [S.I.P.R.E.S. SRL]

Bio-Active Anti-Aging Cream Multi-Protection Daily Renewal SPF 15 Advanced Double Lifting Effect

Biodynamic skin [S.I.P.R.E.S. SRL]

Biodynamic Skin Solution

PubMed Articles [236 Associated PubMed Articles listed on BioPortfolio]

Biotechnology in Europe: A Challenge for Central and East European Countries.

Risk Assessment of Processes and Products in Industrial Biotechnology.

Risk assessment has been used extensively as the main approach to prevent accidents in the chemical and process industry. Industrial biotechnology has many of the same hazards as chemical technology, ...

Asian Congress on Biotechnology 2017.

Editorial overview: Recent progress in analytical technologies for design-build-test-learn cycle in biotechnology.

The global role of biotechnology for non communicable disorders.

The World Health Organization (WHO) has tagged non-communicable diseases (NCDs) as one of the twenty-first century's major development challenges. NCDs account for over 15 million deaths annually and ...

Clinical Trials [13 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Pharmacokinetics of Prana P1 Capsules

This is a single dose clinical trial to assess the Pharmacokinetics of two (2) dosages; 10 mg and 20mg of THC: THCa of Prana P1 bionutrients in healthy volunteers.

A Pilot Scheme - Specimen Collection of Health Management Center

Biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future. The development of biomedical depends on a high quality academic resea...

A Phase III Clinical Trial of a 13-valent Pneumococcal Conjugate Vaccine in Healthy Infants

In order to evaluate immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine produced by Beijing Minhai Biotechnology Co., Ltd., a randomized, double-blind, parallel-contro...

RESULT: Reliable, Emergent Solution Using Liprotamase Treatment

Liprotamase powder is a non-porcine, soluble and stable mixture of biotechnology-derived lipase, protease, and amylase digestive enzymes. The purpose of the present study is to to evaluate...

Salivary Antioxidant Capacity Before and After Complete Dental Rehabilitation

Salivary samples were obtained from 20 children in their fifth year of life diagnosed S-ECC and 20 age and sex matched controls. Complete dental rehabilitation under general anesthesia was...

Companies [891 Associated Companies listed on BioPortfolio]

Prana Biotechnology Limited

Prana Biotechnology was established to commercialise research into Alzheimer's disease and other major age-related neurodegenerative disorders. The Company was incorporated in 1997 and listed on the A...

Prana Biotechnology

Prana Biotechnology has developed a proprietary library of class-leading chemical compounds. This library is combined with a drug development program to explore novel therapeutics in multiple disease ...

Prana Biotechnology Ltd

Prana’s lead candidate, PBT434, is the first of a new generation of small molecules designed to inhibit the aggregation of pathological proteins implicated in neurodegenerati...

Prana

Nil

Task Group Public Perceptions of Biotechnology

The Task Group on Public Perceptions of Biotechnology is one of the six Task Groups of the European Federation of Biotechnology. It was established in 1991, to increase public awareness and understand...

More Information about "Prana Biotechnology" on BioPortfolio

We have published hundreds of Prana Biotechnology news stories on BioPortfolio along with dozens of Prana Biotechnology Clinical Trials and PubMed Articles about Prana Biotechnology for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prana Biotechnology Companies in our database. You can also find out about relevant Prana Biotechnology Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record